zintick

Monte Rosa Therapeutics GLUE

Monte Rosa Therapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$10.85+1.78%close on Oct. 28, 2026 · volume 1.6M · Yahoo Finance

Price, last 47 sessions

$10.00$12.00$14.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $14.56 · low $9.74 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 5, 2026Matthew Bowen
Principal Accounting Officer
Sold13$10.56$137

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 7 →
  • 4Oct. 6, 2026, 4:05 p.m. ETView on SEC.gov
  • 8-KOct. 1, 2026, 7:38 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 8-KSept. 8, 2026, 7:02 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • SCHEDULE 13G/AAug. 14, 2026, 4:23 p.m. ETView on SEC.gov
  • SCHEDULE 13GAug. 14, 2026, 4:10 p.m. ETView on SEC.gov
  • 10-QAug. 6, 2026, 7:09 a.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 7:04 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits